I personally would like to know more about this strategy...
“We have a clear strategy in place to develop and commercialise superior standardised products and to partner with healthcare professionals to develop evidence-based data and personalised treatment solutions for their patients. Our goal is to progress towards commercialisation and with our proprietary final dose form capsules developed, we look forward to having our first product line ready for clinical trials towards the end of 2019.”
- Forums
- ASX - By Stock
- AC8
- Ann: June 2019 Quarterly Activities and Cashflow Reports
Ann: June 2019 Quarterly Activities and Cashflow Reports, page-6
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online